VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 57 filers reported holding VOR BIOPHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,466,562 | -33.2% | 2,106,869 | -2.7% | 0.00% | – |
| Q2 2023 | $6,689,022 | +165.9% | 2,164,732 | +362.9% | 0.00% | – |
| Q1 2023 | $2,515,678 | +59.4% | 467,598 | +97.1% | 0.00% | – |
| Q4 2022 | $1,577,852 | -9.4% | 237,271 | -45.8% | 0.00% | – |
| Q3 2022 | $1,742,000 | -20.3% | 437,621 | -0.6% | 0.00% | – |
| Q2 2022 | $2,187,000 | -73.2% | 440,118 | -67.4% | 0.00% | – |
| Q1 2022 | $8,150,000 | -50.0% | 1,349,245 | -3.9% | 0.00% | – |
| Q4 2021 | $16,307,000 | -8.0% | 1,403,327 | +24.2% | 0.00% | – |
| Q3 2021 | $17,719,000 | +22.8% | 1,130,038 | +46.1% | 0.00% | – |
| Q2 2021 | $14,429,000 | -56.4% | 773,625 | +0.8% | 0.00% | -100.0% |
| Q1 2021 | $33,094,000 | – | 767,816 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $34,226,070 | 8.75% |
| OUP Management Co., LLC | 374,714 | $2,015,961 | 4.02% |
| Paradigm Biocapital Advisors LP | 6,477,999 | $34,851,635 | 3.30% |
| RA Capital Management | 22,748,880 | $122,388,974 | 2.77% |
| JOHNSON & JOHNSON | 1,074,658 | $5,781,660 | 1.88% |
| Artal Group S.A. | 2,792,805 | $15,025 | 0.89% |
| Trustees of Columbia University in the City of New York | 91,910 | $494,476 | 0.88% |
| Sarissa Capital Management LP | 618,000 | $3,324,840 | 0.42% |
| Laurion Capital Management LP | 3,182,889 | $17,123,943 | 0.12% |
| Woodline Partners LP | 1,111,123 | $5,977,842 | 0.08% |